ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies
December 07, 2021Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK... -
Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting
November 11, 2021Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced a Trials in Progress... -
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline
July 15, 2019The fundraiser builds upon Hummingbird's recent momentum in receiving a USD 13.1M product development grant from the CPRIT to support Phase IA/B clinical trials of its anti-VISTA antibody for the treatment of solid tumours and lymphomas
Pharma Sources Insight January 2025
